Market Tracker

10/24 4:13am ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

229.49
Data as of Oct 23
 +4.98 / +2.22%
Today’s Change
46.81
Today|||52-Week Range
497.00
+236.10%
Year-to-Date
No recent news for Intercept Pharmaceuticals Inc.

Today’s Trading

Previous close224.51
Today’s open228.93
Day’s range-- - --
Volume262,738
Average volume (3 months)481,439
Market cap$4.8B
Dividend yield--
Data as of 10/23/2014

Growth & Valuation

Earnings growth (last year)+48.91%
Earnings growth (this year)-247.27%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-33.71%
P/E ratioNM
Price/Sales759.12
Price/Book52.83

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc+1.06+2.54%
SGENSeattle Genetics Inc+0.77+2.21%
GRFSGrifols SA+0.44+1.33%
OPKOPKO Health Inc+0.14+1.70%
Data as of 10/23/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$1.13
Annual revenue (last year)$1.6M
Annual profit (last year)-$67.8M
Net profit margin-4,180.52%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts